CRISPR

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CRISPR and other ETFs, options, and stocks.

About CRSP

CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. Its CRISPR/Cas9 platform is a gene editing technology that allows for precise, directed changes to genomic DNA.

CEO

Samarth Kulkarni

CEOSamarth Kulkarni

Employees

407

Employees407

Headquarters

Zug, Zug

HeadquartersZug, Zug

Founded

2013

Founded2013

Employees

407

Employees407

CRSP Key Statistics

Market cap

4.58B

Market cap4.58B

Price-Earnings ratio

-27.26

Price-Earnings ratio-27.26

Dividend yield

—

Dividend yield—

Average volume

1.30M

Average volume1.30M

High today

$54.94

High today$54.94

Low today

$52.81

Low today$52.81

Open price

$54.00

Open price$54.00

Volume

1.35M

Volume1.35M

52 Week high

$91.10

52 Week high$91.10

52 Week low

$37.55

52 Week low$37.55

CRSP News

Reuters 1d

Regeneron to collaborate on gene editing therapies with Doudna-founded Mammoth

April 25 (Reuters) - Regeneron Pharmaceuticals and Mammoth Biosciences will collaborate to research, develop and commercialize gene editing therapies for multip...

Yahoo Finance 4d

CRISPR Therapeutics AG Stock Sinks As Market Gains: Here's Why - Yahoo Finance

CRISPR Therapeutics AG (CRSP) closed at $55.02 in the latest trading session, marking a -0.05% move from the prior day. The stock's performance was behind the S...

Analyst ratings

52%

of 29 ratings

Buy

51.7%

Hold

37.9%

Sell

10.3%